GPT and metabolic dysfunction-associated steatohepatitis: Early identification of a subpopulation at higher risk for NASH, such as those with elevated ALT or a HOMA-IR ≥2, could optimize the use of local resources by prioritizing those who need further diagnostic assessment with CK-18, TE or liver biopsy.